Literature DB >> 15667412

Hereditary spastic paraplegia with cerebellar ataxia: a complex phenotype associated with a new SPG4 gene mutation.

J E Nielsen1, B Johnsen, P Koefoed, K H Scheuer, M Grønbech-Jensen, I Law, K Krabbe, A Nørremølle, H Eiberg, H Søndergård, M Dam, J F Rehfeld, C Krarup, O B Paulson, L Hasholt, S A Sørensen.   

Abstract

Complex forms of hereditary spastic paraplegia (HSP) are rare and usually transmitted in an autosomal recessive pattern. A family of four generations with autosomal dominant hereditary spastic paraplegia (AD-HSP) and a complex phenotype with variably expressed co-existing ataxia, dysarthria, unipolar depression, epilepsy, migraine, and cognitive impairment was investigated. Genetic linkage analysis and sequencing of the SPG4 gene was performed and electrophysiologic investigations were carried out in six individuals and positron emission tomography (PET) in one patient. The disease was linked to the SPG4 locus on chromosome 2p as previously reported for pure HSP. Sequence analysis of the SPG4 (spastin) gene identified a novel 1593 C > T (GLN490Stop) mutation leading to premature termination of exon 12 with ensuing truncation of the encoded protein. However, the mutation was only identified in those individuals who were clinically affected by a complex phenotype consisting of HSP and cerebellar ataxia. Other features noted in this kindred including epilepsy, cognitive impairment, depression, and migraine did not segregate with the HSP phenotype or mutation, and therefore the significance of these features to SPG4 is unclear. Electrophysiologic investigation showed increased central conduction time at somatosensory evoked potentials measured from the lower limbs as the only abnormal finding in two affected individuals with the SPG4 mutation. Moreover, PET of one patient showed significantly relatively decreased regional cerebral blood flow in most of the cerebellum. We conclude that this kindred demonstrates a considerable overlap between cerebellar ataxia and spastic paraplegia, emphasizing the marked clinical heterogeneity of HSP associated with spastin mutations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15667412     DOI: 10.1111/j.1468-1331.2004.00888.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  20 in total

1.  Complex phenotype in an Italian family with a novel mutation in SPG3A.

Authors:  Maria Fulvia de Leva; Alessandro Filla; Chiara Criscuolo; Alessandra Tessa; Sabina Pappatà; Mario Quarantelli; Leonilda Bilo; Silvio Peluso; Antonella Antenora; Dario Longo; Filippo M Santorelli; Giuseppe De Michele
Journal:  J Neurol       Date:  2009-09-19       Impact factor: 4.849

2.  The Alu-rich genomic architecture of SPAST predisposes to diverse and functionally distinct disease-associated CNV alleles.

Authors:  Philip M Boone; Bo Yuan; Ian M Campbell; Jennifer C Scull; Marjorie A Withers; Brett C Baggett; Christine R Beck; Christine J Shaw; Pawel Stankiewicz; Paolo Moretti; Wendy E Goodwin; Nichole Hein; John K Fink; Moon-Woo Seong; Soo Hyun Seo; Sung Sup Park; Izabela D Karbassi; Sat Dev Batish; Andrés Ordóñez-Ugalde; Beatriz Quintáns; María-Jesús Sobrido; Susanne Stemmler; James R Lupski
Journal:  Am J Hum Genet       Date:  2014-07-24       Impact factor: 11.025

3.  A novel SPAST frameshift mutation in a Chinese family with hereditary spastic paraplegia.

Authors:  Wang Yuliang; Wang Yuan; Wang Xuezhen; Ma He; Zheng Qi; Chen Jinbo
Journal:  Neurol Sci       Date:  2016-09-14       Impact factor: 3.307

Review 4.  Hereditary spastic paraplegias: membrane traffic and the motor pathway.

Authors:  Craig Blackstone; Cahir J O'Kane; Evan Reid
Journal:  Nat Rev Neurosci       Date:  2011-01       Impact factor: 34.870

5.  Gray and white matter alterations in hereditary spastic paraplegia type SPG4 and clinical correlations.

Authors:  Tobias Lindig; Benjamin Bender; Till-Karsten Hauser; Sarah Mang; Daniel Schweikardt; Uwe Klose; Kathrin N Karle; Rebecca Schüle; Ludger Schöls; Tim W Rattay
Journal:  J Neurol       Date:  2015-06-09       Impact factor: 4.849

6.  Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from that observed in familial cases.

Authors:  C Depienne; C Tallaksen; J Y Lephay; B Bricka; S Poea-Guyon; B Fontaine; P Labauge; A Brice; A Durr
Journal:  J Med Genet       Date:  2005-07-31       Impact factor: 6.318

7.  Partial SPAST and DPY30 deletions in a Japanese spastic paraplegia type 4 family.

Authors:  Shiroh Miura; Hiroki Shibata; Hiroshi Kida; Kazuhito Noda; Takayuki Toyama; Naoka Iwasaki; Akiko Iwaki; Mitsuyoshi Ayabe; Hisamichi Aizawa; Takayuki Taniwaki; Yasuyuki Fukumaki
Journal:  Neurogenetics       Date:  2010-09-22       Impact factor: 2.660

Review 8.  Hereditary spastic paraplegia SPG4: what is known and not known about the disease.

Authors:  Joanna M Solowska; Peter W Baas
Journal:  Brain       Date:  2015-06-20       Impact factor: 13.501

Review 9.  Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms.

Authors:  John K Fink
Journal:  Acta Neuropathol       Date:  2013-07-30       Impact factor: 17.088

Review 10.  Hereditary spastic paraplegia.

Authors:  John K Fink
Journal:  Curr Neurol Neurosci Rep       Date:  2006-01       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.